Prognostic role of expression of N-cadherin in patients with upper tract urothelial carcinoma: a multi-institutional study
Open Access
- 9 November 2016
- journal article
- research article
- Published by Springer Nature in World Journal of Urology
- Vol. 35 (7) , 1073-1080
Abstract
Purpose To assess the role of N-cadherin as prognostic biomarker in patients with upper tract urothelial carcinoma (UTUC) in a large multi-institutional cohort of patients. Patients and methods Immunohistochemistry was used to evaluate the status of N-cadherin expression in 678 patients with unilateral sporadic UTUC treated with radical nephroureterectomy. N-cadherin was considered positive if any immunoreactivity with membranous staining was detected. The Kaplan–Meier method was used to estimate recurrence-free survival, overall survival and cancer-specific survival. Disease recurrence, overall mortality and cancer-specific mortality probabilities were tested in Cox regression models. Results Expression of N-cadherin was observed in 292 (43.1%) of patients, and it was associated with advanced tumour stage (p < 0.04), lymph node metastases (p = 0.04) and sessile architecture (p < 0.02). Within a median follow-up of 37.5 months (IQR 20–66), 171 patients (25.2%) experienced disease recurrence and 150 (22.1%) died from UTUC. In univariable analyses, N-cadherin expression was significantly associated with higher probability of recurrence (p = 0.01), but not overall (p = 0.9) or cancer-specific mortality (p = 0.06). When adjusted for the effects of all available confounders, N-cadherin was not associated with any of the survival outcomes. Conclusion N-cadherin is expressed in approximately 2/5 of UTUs. It is associated with adverse pathologic factors but not with survival outcomes. Its clinical value remains limited.Keywords
This publication has 29 references indexed in Scilit:
- The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part B: Prostate and Bladder TumoursEuropean Urology, 2016
- European Guidelines on Upper Tract Urothelial Carcinomas: 2013 UpdateEuropean Urology, 2013
- Prognostic Factors in Upper Urinary Tract Urothelial Carcinomas: A Comprehensive Review of the Current LiteratureEuropean Urology, 2012
- Expression Profile of E-cadherin and N-cadherin in Urothelial Carcinoma of the Upper Urinary Tract is Associated with Disease Recurrence in Patients Undergoing NephroureterectomyUrology, 2011
- Tumour Necrosis Is an Indicator of Aggressive Biology in Patients with Urothelial Carcinoma of the Upper Urinary TractEuropean Urology, 2010
- The basics of epithelial-mesenchymal transitionJournal of Clinical Investigation, 2009
- Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi‐institutional analysis of 1363 patientsBJU International, 2009
- Challenges of Cancer Biomarker ProfilingEuropean Urology, 2007
- N-Cadherin as a Novel Prognostic Marker of Progression in Superficial Urothelial TumorsClinical Cancer Research, 2006
- Tissue Microarray Analysis of the Prognostic Value of E-Cadherin, Ki67, p53, p27, Survivin and MSH2 Expression in Upper Urinary Tract Transitional Cell CarcinomaEuropean Urology, 2005